Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

193.24
+7.113.82%
Pre-market: 193.630.3900+0.20%05:37 EDT
Volume:3.25M
Turnover:629.08M
Market Cap:12.72B
PE:-86.68
High:197.19
Open:188.75
Low:187.05
Close:186.13
52wk High:197.19
52wk Low:23.30
Shares:65.83M
Float Shares:64.65M
Volume Ratio:1.14
T/O Rate:5.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2293
EPS(LYR):-1.2987
ROE:-29.59%
ROA:-13.09%
PB:28.54
PE(LYR):-148.80

Loading ...

Twist Bioscience upgraded to Outperform from Market Perform at Leerink

TIPRANKS
·
May 05

Twist Bioscience Corp : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $70 From $55

THOMSON REUTERS
·
May 05

Twist Bioscience Corp : TD Cowen Raises Target Price to $68 From $58

THOMSON REUTERS
·
May 05

Twist Bioscience price target raised to $65 from $55 at Barclays

TIPRANKS
·
May 05

Stock Track | Twist Bioscience Plummets 5.97% Intraday After Reporting Wider-Than-Expected Quarterly Loss

Stock Track
·
May 04

Twist Bioscience Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 04

Twist Bioscience Outlook FY Revenue USD 442-447 Million

THOMSON REUTERS
·
May 04

Twist Bioscience FY26 Q2 net loss widens to $44 million; revenue rises 19% to $110.7 million

Reuters
·
May 04

GUIDANCE: (TWST) Twist Bioscience Expects Fiscal Q3 Revenue Range $114M to $115M, vs. FactSet Est of $111.3M

MT Newswires Live
·
May 04

Earnings Flash (TWST) Twist Bioscience Posts Fiscal Q2 Loss $0.71 a Share, vs. FactSet Est of $0.50 Loss

MT Newswires Live
·
May 04

Twist Bioscience posts fiscal 2026 Q2 earnings report, investor presentation online

Reuters
·
May 04

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

THOMSON REUTERS
·
May 04

Twist Bioscience Corp Outlook Q3 Total Revenue of Approximately $114 Million to $115 Million

THOMSON REUTERS
·
May 04

Twist Bioscience Corp Q3 REV View $111.4 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
May 04

Twist Bioscience director Melissa Starovasnik sells 500 shares worth $30,915

Reuters
·
Apr 30

Earning Preview: Twist Bioscience Corp revenue expected to increase by 17.03% this quarter, and institutional views are bullish

Earnings Agent
·
Apr 27

Twist Bio CFO Adam Laponis disposes of 4,000 shares worth $240,000

Reuters
·
Apr 22

Press Release: Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

Dow Jones
·
Apr 21

Twist Bioscience CFO Adam Laponis sells 3,000 shares worth $165,000

Reuters
·
Apr 17

Twist Bioscience Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15